Navigation Links
Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
Date:11/15/2007

ion that may slow the onset of future bacterial resistance. In addition to its utility in CAP, cethromycin is also being investigated for the prophylactic treatment of inhalation anthrax post-exposure. The FDA has designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the drug is not yet approved for this or any other indication.

About John Bartlett, M.D.

Dr. Bartlett is a Professor of Medicine in the Division of Infectious Diseases at The Johns Hopkins University School of Medicine, Baltimore, Maryland. He received his undergraduate degree at Dartmouth in 1959 and his medical degree at Upstate Medical Center in Syracuse in 1963. His training in internal medicine was done at the Brigham Hospital in Boston and the University of Alabama, after which he received his fellowship training in infectious diseases at UCLA. In 1970, he joined the faculty of UCLA, and then joined the faculty of Tufts University School of Medicine where he served as Associate Chief of Staff for Research at the Boston VA Hospital. In 1980, he moved to Hopkins where he served as Chief of the Infectious Diseases Division at the School for 26 years, stepping down in June of 2006.

Dr. Bartlett is a past president of the Infectious Disease Society of America (IDSA) and an author of the IDSA/ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia. He was an author of "Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America," which was published in Clinical Infectious Diseases in 2006. He has authored over 500 articles and reviews in peer-reviewed journals, more than 280 book chapters, and 67 editions of 18 books. He has also served on editorial boards for 19 medical journals including Infectious Diseases in Clinical Practice (Editor) and Clinical Infectious Diseases Medicine (Associate Editor).

About Donald
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
4. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
5. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
6. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
9. Spherix Reports Second Quarter Earnings
10. Tapestry Reports Second Quarter 2007 Results
11. Callisto Reports on Second-Quarter 2007 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... health affects a man,s lifestyle, and if he wants to ... he should address any hearing loss he may be experiencing. ... Institute (BHI) is delivering to men around the country ... leads up to and includes Father,s Day. This year, National ... To help men address their hearing health ...
(Date:5/23/2013)... recently published clinical study conducted at TOPS Comprehensive Breast ... that 3D mammography (breast tomosynthesis) significantly reduces unnecessary recalls ... study, "Implementation of Breast Tomosynthesis in a Routine Screening ... Stephen L. Rose , MD, and published in ... Roentgenology (AJR). The AJR is the scientific journal ...
(Date:5/23/2013)... May 23, 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, ... companies, based on intellectual property developed and owned ... ,s foremost medical research center, today announced that ... significant funding from the Israeli Ministry of Industry ... to support product development and advance clinical trials. ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... , GENEVA, Switzerland, May 2, 2007 – Merck,Serono ... data on,safinamide, a new agent in Phase III ... presented by Professor,Fabrizio Stocchi at the American Academy ... These data are from a,6-month (24 weeks), randomized, ...
... THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Apr 30, 2007 ... from a pivotal Phase 3,trial which ... human,monoclonal antibody directed against the epidermal ... (PFS) compared,to best supportive care (BSC) ...
Cached Medicine Technology:Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 2Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 3Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 4Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 5Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 2Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 3Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 4Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 5Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 6
(Date:5/25/2013)... On May 20, 2013 the Sydney Morning ... discuss or plan for their eventual demise, but it is ... a Must-Do List to help people properly arrange for their ... personal fact sheet.” , While not a formal document, this ... data. It may include a summary of assets, debts, ...
(Date:5/25/2013)... May 25, 2013 By working diligently ... declared the integration of the 2012 Lamborghini Aventador into ... the latest entrant in the list of vehicles lined ... vehicle is all set to thrill automobile lovers in ... power and spectacular looks, the 2012 Lamborghini Aventador comes ...
(Date:5/25/2013)... Many orthodontists have thought about moving their office to ... Most people would naturally assume that the company ... service and support would own and maintain all the ... be wrong. Cloud providers lease space in a ... houses servers and related equipment to run cloud environments) ...
(Date:5/25/2013)... Plains, NJ (PRWEB) May 25, 2013 ... iPhone. The universal app version of Word Hunt ... app versions of Concentration, Edge Match, Flash 2, Sudoku and ... , The brain games’ gameplay and revolutionary lifetime brain fitness ... 4 inch displays. , “100 years of brain fitness measurement ...
(Date:5/25/2013)... Bradley, Illinois (PRWEB) May 25, 2013 ... assisted living community, is hosting an American Red Cross ... May 30. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... give the Gift of Life," says Andrea Arview Frey, ...
Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Acuity Games Apps Come to the iPhone 2Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2
... new study by the NYU Cancer Institute, an NCI-designated ... leukemia, a type of blood cancer that affects children ... an intracellular communication pathway called Notch led to the ... this disease. Notch has already been implicated in another ...
... nine-years-old can start to show an increased risk of future heart ... the May issue of Acta Paediatrica . ... studied 223 children 123 boys and 100 girls with ... over four days. They found that the children who were ...
... appears to have a genetic basis, at least in part. ... small reins) plays a key role in this process, as ... Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now shown. ... to nicotine ( Neuron , May,12, 2011, Vol. 70, Issue ...
... 12 (HealthDay News) -- Music hath charms to protect the ... Northwestern University researchers who compared adults aged 45 to 65 ... to confer advantages in at least two important functions known ... hear speech in noise," study co-author Nina Kraus, director of ...
... at the edge of an ice hole, an Antarctic emperor ... the bird descends and may not emerge again for another ... stores the blood, lungs and myoglobin in muscle ... the surface, lactate begins appearing in the penguin,s blood and ...
... a smoker,s chance of quitting, according to new research published ... This study is the first to assess the effectiveness of ... The research, which was carried out by scientists at the ... enrolled in a programme to help them quit smoking. ...
Cached Medicine News:Health News:Study reveals origins of a cancer affecting the blood and bone marrow 2Health News:Lack of exercise linked to higher heart disease risk in healthy children as young as 9 2Health News:Reining in nicotine use 2Health News:Musicians Maintain Memory, Hearing as They Age 2Health News:Penguins continue diving long after muscles run out of oxygen 2Health News:Penguins continue diving long after muscles run out of oxygen 3
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
... With the Symphony family of Pacemakers, Ela ... market. Symphony, lighter than a passport, will ... using new technologies, and delivering powerful monitoring. ... for dual-chamber and atrial tracking modes in ...
Medicine Products: